This is a record

Captured June 15, 2021 1:53 pm

View Mode: Standard Screenshot
View the live page
What is Perma.cc?
Title
Two members of an FDA advisory committee quit after approval of controversial Alzheimer’s drug - The Washington Post
Description
The FDA decision to approve Aduhelm set off a firestorm because critics say there is scant evidence the drug is effective.
Download WARC Flag as inappropriate